BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 18368133)

  • 1. Xeroderma pigmentosum-variant patients from America, Europe, and Asia.
    Inui H; Oh KS; Nadem C; Ueda T; Khan SG; Metin A; Gozukara E; Emmert S; Slor H; Busch DB; Baker CC; DiGiovanna JJ; Tamura D; Seitz CS; Gratchev A; Wu WH; Chung KY; Chung HJ; Azizi E; Woodgate R; Schneider TD; Kraemer KH
    J Invest Dermatol; 2008 Aug; 128(8):2055-68. PubMed ID: 18368133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rare exon 10 deletion in POLH gene in a family with xeroderma pigmentosum variant correlating with protein expression by immunohistochemistry.
    Borroni RG; Diegoli M; Grasso M; Concardi M; Agozzino M; Vignini M; Arbustini E
    G Ital Dermatol Venereol; 2020 Jun; 155(3):349-354. PubMed ID: 32635709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a novel nonsense mutation in POLH in a Chinese pedigree with xeroderma pigmentosum, variant type.
    Liu X; Zhang X; Qiao J; Fang H
    Int J Med Sci; 2013; 10(6):766-70. PubMed ID: 23630442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of phenotype/genotype in a cohort of 23 xeroderma pigmentosum-variant patients reveals 12 new disease-causing POLH mutations.
    Opletalova K; Bourillon A; Yang W; Pouvelle C; Armier J; Despras E; Ludovic M; Mateus C; Robert C; Kannouche P; Soufir N; Sarasin A
    Hum Mutat; 2014 Jan; 35(1):117-28. PubMed ID: 24130121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced XPC DNA repair gene mRNA levels in clinically normal parents of xeroderma pigmentosum patients.
    Khan SG; Oh KS; Shahlavi T; Ueda T; Busch DB; Inui H; Emmert S; Imoto K; Muniz-Medina V; Baker CC; DiGiovanna JJ; Schmidt D; Khadavi A; Metin A; Gozukara E; Slor H; Sarasin A; Kraemer KH
    Carcinogenesis; 2006 Jan; 27(1):84-94. PubMed ID: 16081512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular analysis of DNA polymerase eta gene in Japanese patients diagnosed as xeroderma pigmentosum variant type.
    Tanioka M; Masaki T; Ono R; Nagano T; Otoshi-Honda E; Matsumura Y; Takigawa M; Inui H; Miyachi Y; Moriwaki S; Nishigori C
    J Invest Dermatol; 2007 Jul; 127(7):1745-51. PubMed ID: 17344931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Frameshift Variants in
    Zamani GY; Khan R; Karim N; Ahmed ZM; Naeem M
    Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular genetic analysis of 16 XP-C patients from Germany: environmental factors predominately contribute to phenotype variations.
    Schäfer A; Hofmann L; Gratchev A; Laspe P; Schubert S; Schürer A; Ohlenbusch A; Tzvetkov M; Hallermann C; Reichrath J; Schön MP; Emmert S
    Exp Dermatol; 2013 Jan; 22(1):24-9. PubMed ID: 23173980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular genetics of Xeroderma pigmentosum variant.
    Gratchev A; Strein P; Utikal J; Sergij G
    Exp Dermatol; 2003 Oct; 12(5):529-36. PubMed ID: 14705792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overproduction of DNA polymerase eta does not raise the spontaneous mutation rate in diploid human fibroblasts.
    King NM; Nikolaishvili-Feinberg N; Bryant MF; Luche DD; Heffernan TP; Simpson DA; Hanaoka F; Kaufmann WK; Cordeiro-Stone M
    DNA Repair (Amst); 2005 Jun; 4(6):714-24. PubMed ID: 15886068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular analysis of mutations in DNA polymerase eta in xeroderma pigmentosum-variant patients.
    Broughton BC; Cordonnier A; Kleijer WJ; Jaspers NG; Fawcett H; Raams A; Garritsen VH; Stary A; Avril MF; Boudsocq F; Masutani C; Hanaoka F; Fuchs RP; Sarasin A; Lehmann AR
    Proc Natl Acad Sci U S A; 2002 Jan; 99(2):815-20. PubMed ID: 11773631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational spectrum of Xeroderma pigmentosum group A in Egyptian patients.
    Amr K; Messaoud O; El Darouti M; Abdelhak S; El-Kamah G
    Gene; 2014 Jan; 533(1):52-6. PubMed ID: 24135642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant C-terminal domain of polymerase η targets the functional enzyme to the proteosomal degradation pathway.
    Ahmed-Seghir S; Pouvelle C; Despras E; Cordonnier A; Sarasin A; Kannouche PL
    DNA Repair (Amst); 2015 May; 29():154-65. PubMed ID: 25766642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of Xeroderma pigmentosum variant in a young patient with two novel mutations in the POLH gene.
    De Palma A; Morren MA; Ged C; Pouvelle C; Taïeb A; Aoufouchi S; Sarasin A
    Am J Med Genet A; 2017 Sep; 173(9):2511-2516. PubMed ID: 28688171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translesion replication in cisplatin-treated xeroderma pigmentosum variant cells is also caffeine-sensitive: features of the error-prone DNA polymerase(s) involved in UV-mutagenesis.
    Yamada K; Takezawa J; Ezaki O
    DNA Repair (Amst); 2003 Aug; 2(8):909-24. PubMed ID: 12893087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Iberian legacy into a young genetic xeroderma pigmentosum cluster in central Brazil.
    Castro LP; Sahbatou M; Kehdy FSG; Farias AA; Yurchenko AA; de Souza TA; Rosa RCA; Mendes-Junior CT; Borda V; Munford V; Zanardo ÉA; Chehimi SN; Kulikowski LD; Aquino MM; Leal TP; Tarazona-Santos E; Chaibub SC; Gener B; Calmels N; Laugel V; Sarasin A; Menck CFM
    Mutat Res Genet Toxicol Environ Mutagen; 2020 Apr; 852():503164. PubMed ID: 32265042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human DNA polymerase eta activity and translocation is regulated by phosphorylation.
    Chen YW; Cleaver JE; Hatahet Z; Honkanen RE; Chang JY; Yen Y; Chou KM
    Proc Natl Acad Sci U S A; 2008 Oct; 105(43):16578-83. PubMed ID: 18946034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. hRAD30 mutations in the variant form of xeroderma pigmentosum.
    Johnson RE; Kondratick CM; Prakash S; Prakash L
    Science; 1999 Jul; 285(5425):263-5. PubMed ID: 10398605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical, cellular, and molecular features of an Israeli xeroderma pigmentosum family with a frameshift mutation in the XPC gene: sun protection prolongs life.
    Slor H; Batko S; Khan SG; Sobe T; Emmert S; Khadavi A; Frumkin A; Busch DB; Albert RB; Kraemer KH
    J Invest Dermatol; 2000 Dec; 115(6):974-80. PubMed ID: 11121128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A role for polymerase eta in the cellular tolerance to cisplatin-induced damage.
    Albertella MR; Green CM; Lehmann AR; O'Connor MJ
    Cancer Res; 2005 Nov; 65(21):9799-806. PubMed ID: 16267001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.